Context: Polycystic ovary syndrome (PCOS) affects 10% of women of reproductive age. The genetic architecture of the disease is emerging, but there is little data exploring the effect of genetic risk on clinical presentation.
Objective: We hypothesized that genetic risk loci would influence measurable phenotypic traits.
J Clin Endocrinol Metab
November 2024
Context: DNA damage/repair gene variants are associated with both primary ovarian insufficiency (POI) and cancer risk.
Objective: We hypothesized that a subset of women with POI and family members would have increased risk for cancer.
Design: Case-control population-based study using records from 1995-2022.
We created the c.1286C>G stop-gain mutation found in a family with primary ovarian insufficiency (POI) at age 30 years. The C57/Bl6 transgenic mouse model contained a floxed exon 10-19 cassette with a conditional knock-in cassette containing the c.
View Article and Find Full Text PDFAging Cell
November 2023
Muscle inflammation and fibrosis underlie disuse-related complications and may contribute to impaired muscle recovery in aging. Cellular senescence is an emerging link between inflammation, extracellular matrix (ECM) remodeling and poor muscle recovery after disuse. In rodents, metformin has been shown to prevent cellular senescence/senescent associated secretory phenotype (SASP), inflammation, and fibrosis making it a potentially practical therapeutic solution.
View Article and Find Full Text PDFContext: A genetic etiology accounts for the majority of unexplained primary ovarian insufficiency (POI).
Objective: We hypothesized a genetic cause of POI for a sister pair with primary amenorrhea.
Design: The study was an observational study.
Objective: To determine the familiality of primary ovarian insufficiency (POI) at population level through examination of multigenerational genealogical information linked to electronic medical records.
Design: Case-control study.
Setting: Not applicable.
Context: Polycystic ovarian syndrome (PCOS) is a complex disorder in which metabolic abnormalities are associated with reproductive dysfunction. Women with PCOS have increased ceramide concentrations. Previous studies demonstrated that treating metabolic abnormalities of PCOS with metformin improved glucose effectiveness after 12 weeks.
View Article and Find Full Text PDFStudy Question: What is known about health-related quality of life (HR-QoL) in women with idiopathic primary ovarian insufficiency (POI)?
Summary Answer: Women with POI have a range of unmet psychosocial needs relating to three interrelated themes: 'diagnostic odyssey', 'isolation and stigma' and impaired 'ego integrity'.
What Is Known Already: Prior studies have reported increased depressive symptoms, diminished sexual function and altered body image/self-concept in women with POI.
Study Design, Size, Duration: A systematic scoping review (11 databases) on HR-QoL in POI including published quantitative, qualitative and mixed-methods studies as well as unpublished gray literature (i.
Context: A genetic etiology likely accounts for the majority of unexplained primary ovarian insufficiency (POI).
Objective: We hypothesized that heterozygous rare variants and variants in enhanced categories are associated with POI.
Design: The study was an observational study.
The approach to hyperandrogenism in women varies depending on the woman's age and severity of symptoms. Once tumorous hyperandrogenism is excluded, the most common cause is PCOS. Hirsutism is the most common presenting symptom.
View Article and Find Full Text PDFObjective: Primary ovarian insufficiency (POI) and Non-obstructive azoospermia (NOA) both represent disease states of early, and often complete, failure of gametogenesis. Because oogenesis and spermatogenesis share the same conserved steps in meiosis I, it is possible that inherited defects in meiosis I could lead to shared causes of both POI and NOA. Currently, known genes that contribute to both POI and NOA are limited.
View Article and Find Full Text PDFObjective: To identify modifying genes that explains the risk of fragile X-associated primary ovarian insufficiency (FXPOI).
Design: Gene-based, case/control association study, followed by a functional screen of highly ranked genes using a Drosophila model.
Setting: Participants were recruited from academic and clinical settings.
To provide a multi-omics resource and investigate transcriptional regulatory mechanisms, we profile the transcriptome, chromatin accessibility, and methylation status of over 70,000 single nuclei (sn) from adult mouse pituitaries. Paired snRNAseq and snATACseq datasets from individual animals highlight a continuum between developmental epigenetically-encoded cell types and transcriptionally-determined transient cell states. Co-accessibility analysis-based identification of a putative Fshb cis-regulatory domain that overlaps the fertility-linked rs11031006 human polymorphism, followed by experimental validation illustrate the use of this resource for hypothesis generation.
View Article and Find Full Text PDFJ Clin Endocrinol Metab
July 2021
Context: Isolated prolactin deficiency is a rare disorder manifesting as absence of puerperal lactation. We identified a 2-generation family with 3 women experiencing alactogenesis.
Objective: We hypothesized a heterozygous genetic mutation.
Polycystic ovary syndrome (PCOS) is a complex genetic disorder with many genetic loci contributing small risk. Large genome-wide association studies identified 21 genetic risk loci for PCOS in European and Han Chinese women. The genetic architecture is similar across PCOS diagnostic categories.
View Article and Find Full Text PDFContext: Functional hypothalamic amenorrhea (HA) is a common, acquired form of hypogonadotropic hypogonadism that occurs in the setting of energy deficits and/or stress. Variability in individual susceptibility to these stressors, HA heritability, and previous identification of several rare sequence variants (RSVs) in genes associated with the rare disorder, isolated hypogonadotropic hypogonadism (IHH), in individuals with HA suggest a possible genetic contribution to HA susceptibility.
Objective: We sought to determine whether the burden of RSVs in IHH-related genes is greater in women with HA than controls.
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
View Article and Find Full Text PDFPolycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. Affected women frequently have metabolic disturbances including insulin resistance and dysregulation of glucose homeostasis. PCOS is diagnosed with two different sets of diagnostic criteria, resulting in a phenotypic spectrum of PCOS cases.
View Article and Find Full Text PDFJ Clin Endocrinol Metab
February 2019
Context: Menstrual irregularity after menarche has been attributed to immature estrogen positive feedback activity (E+FB) but data are conflicting.
Objective: To determine the hypothalamic-pituitary-ovarian contributions to menstrual irregularity in adolescents.
Methods: Twenty-three healthy girls [aged 12.
Context: Primary ovarian insufficiency (POI) results from a premature loss of oocytes, causing infertility and early menopause. The etiology of POI remains unknown in a majority of cases.
Objective: To identify candidate genes in families affected by POI.